{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:00:37Z","timestamp":1794621637113,"version":"4.9.1"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05653-8","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:51:29Z","timestamp":1760457089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Optimal antibiotic use in the intensive care unit"],"prefix":"10.1186","volume":"29","author":[{"given":"Scott T.","family":"Micek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Vazquez Guillamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Matuszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kolodziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin H.","family":"Kollef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"15","key":"5653_CR1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"J Vincent","year":"2020","unstructured":"Vincent J, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478\u201387.","journal-title":"JAMA"},{"issue":"16","key":"5653_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.1993.03510160083034","volume":"270","author":"MH Kollef","year":"1993","unstructured":"Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA. 1993;270(16):1965\u201370.","journal-title":"JAMA"},{"issue":"3","key":"5653_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.2201","volume":"39","author":"BF Teshome","year":"2019","unstructured":"Teshome BF, Vouri SM, Hampton N, Kollef MH, Micek ST. Duration of exposure to antipseudomonal \u03b2-lactam antibiotics in the critically ill and development of new resistance. Pharmacotherapy. 2019;39(3):261\u201370.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"5653_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/cid\/ciae259","volume":"79","author":"MJ Ray","year":"2024","unstructured":"Ray MJ, Strnad LC, Tucker KJ, Furuno JP, Lofgren ET, McCracken CM, et al. Influence of antibiotic exposure intensity on the risk of Clostridioides difficile infection. Clin Infect Dis. 2024;79(5):1129\u201335.","journal-title":"Clin Infect Dis"},{"issue":"19","key":"5653_CR5","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon J, Cjevret S, WermertD, TF, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588\u201398.","journal-title":"JAMA"},{"issue":"6","key":"5653_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper. Intensive Care Med. 2020;46(6):1127\u201353.","journal-title":"Intensive Care Med"},{"issue":"10","key":"5653_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9100676","volume":"9","author":"C Adembri","year":"2020","unstructured":"Adembri C, Novelli A, Nobili S. Some suggestions from PK\/PD principles to contain resistance in the clinical setting-focus on ICU patients and gram-negative strains. Antibiotics. 2020;9(10):676.","journal-title":"Antibiotics"},{"issue":"6","key":"5653_CR8","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.chest.2020.06.034","volume":"158","author":"SP Bergen","year":"2020","unstructured":"Bergen SP, Coles A, Calvert SB, Farly J, Powers JH, Zervos MJ, et al. PROPHETIC: Prospective identification of pneumonia in hospitalized patients in the ICU. Chest. 2020;158(6):2370\u201380.","journal-title":"Chest"},{"issue":"1","key":"5653_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmi.2019.07.007","volume":"26","author":"KJ Denny","year":"2020","unstructured":"Denny KJ, De Wale J, Laupland KB, Harris PNA, Lipman J. When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit. Clin Microbiol Infect. 2020;26(1):35\u201340.","journal-title":"Clin Microbiol Infect"},{"key":"5653_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1086\/650580","volume":"50","author":"AC Heffner","year":"2010","unstructured":"Heffner AC, Horton JM, Marchick MR, Jones AE. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50:814\u201320.","journal-title":"Clin Infect Dis"},{"key":"5653_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13054-015-1035-1","volume":"19","author":"PMC Klein Klouwenberg","year":"2015","unstructured":"Klein Klouwenberg PMC, Cremer OL, van Vught LA, Ong DSY, Frencken JF, Schultz MJ, et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care. 2015;19:319.","journal-title":"Crit Care"},{"key":"5653_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1097\/CCM.0000000000003260","volume":"46","author":"MR Filbin","year":"2018","unstructured":"Filbin MR, Lynch J, Gillingham TD, Thorsen JE, Pasakarnis CL, Nepal S, et al. Presenting symptoms independently predict mortality in septic shock: importance of a previously unmeasured confounder. Crit Care Med. 2018;46:1592\u20139.","journal-title":"Crit Care Med"},{"issue":"11","key":"5653_CR13","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"key":"5653_CR14","unstructured":"QualityNet Home [Internet]. [cited 2025 Jul 5]. Available from: https:\/\/qualitynet.cms.gov\/"},{"key":"5653_CR15","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589\u201396.","journal-title":"Crit Care Med"},{"key":"5653_CR16","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376:2235\u201344.","journal-title":"N Engl J Med"},{"key":"5653_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196:856\u201363.","journal-title":"Am J Respir Crit Care Med"},{"key":"5653_CR18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749\u201355.","journal-title":"Crit Care Med"},{"key":"5653_CR19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.chest.2019.02.008","volume":"155","author":"ID Peltan","year":"2019","unstructured":"Peltan ID, Brown SM, Bledsoe JR, Sorensen J, Samore MH, Allen TL, et al. ED door-to-antibiotic time and long-term mortality in sepsis. Chest. 2019;155:938\u201346.","journal-title":"Chest"},{"key":"5653_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.amjmed.2019.09.012","volume":"133","author":"BS Ko","year":"2020","unstructured":"Ko BS, Choi S-H, Kang GH, Shin TG, Kim K, Jo YH, et al. Time to antibiotics and the outcome of patients with septic shock: A propensity score analysis. Am J Med. 2020;133:485-491.e4.","journal-title":"Am J Med"},{"key":"5653_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/cid\/cix997","volume":"66","author":"Infectious Diseases Society of America (IDSA)","year":"2018","unstructured":"Infectious Diseases Society of America (IDSA). Position statement: why IDSA did not endorse the surviving sepsis campaign guidelines. Clin Infect Dis. 2018;66:1631\u20135.","journal-title":"Clin Infect Dis"},{"key":"5653_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciaa059","volume":"72","author":"C Rhee","year":"2020","unstructured":"Rhee C, Chiotos K, Cosgrove SE, Heil EL, Kadri SS, Kalil AC, et al. Infectious diseases society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure. Clin Infect Dis. 2020;72:541\u201352.","journal-title":"Clin Infect Dis"},{"key":"5653_CR23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","volume":"12","author":"T Hranjec","year":"2012","unstructured":"Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 2012;12:774\u201380.","journal-title":"Lancet Infect Dis"},{"key":"5653_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21:241\u201351.","journal-title":"Lancet Infect Dis"},{"key":"5653_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma T, Chihara S, Costin B, Treggiari MM, Bartz RR, Raghunathan K, et al. Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw Open. 2023;6:e2249353.","journal-title":"JAMA Netw Open"},{"key":"5653_CR26","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1378\/chest.09-0087","volume":"136","author":"A Kumar","year":"2009","unstructured":"Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136:1237\u201348.","journal-title":"Chest"},{"key":"5653_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38:1045\u201353.","journal-title":"Crit Care Med"},{"key":"5653_CR28","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/CCM.0000000000000516","volume":"42","author":"C Vazquez-Guillamet","year":"2014","unstructured":"Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med. 2014;42:2342\u20139.","journal-title":"Crit Care Med"},{"issue":"3","key":"5653_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/cid\/ciw283","volume":"63","author":"S Karanika","year":"2016","unstructured":"Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63(3):310\u20138.","journal-title":"Clin Infect Dis"},{"key":"5653_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1469-0691.12747","volume":"20","author":"M Giannella","year":"2014","unstructured":"Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20:1357\u201362.","journal-title":"Clin Microbiol Infect"},{"key":"5653_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.43658","volume":"7","author":"MC Vazquez Guillamet","year":"2024","unstructured":"Vazquez Guillamet MC, Liu H, Atkinson A, Fraser VJ, Lu C, Kollef MH. Performance of risk models for antimicrobial resistance in adult patients with sepsis. JAMA Netw Open. 2024;7:e2443658.","journal-title":"JAMA Netw Open"},{"key":"5653_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, Danner RL, Chen H-C, Fram D, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020;3:e202899.","journal-title":"JAMA Netw Open"},{"key":"5653_CR33","doi-asserted-by":"publisher","first-page":"1900057","DOI":"10.1183\/13993003.00057-2019","volume":"54","author":"BJ Webb","year":"2019","unstructured":"Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC. Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J. 2019;54:1900057.","journal-title":"Eur Respir J"},{"key":"5653_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cid\/ciaf039","volume":"80","author":"JD Baghdadi","year":"2025","unstructured":"Baghdadi JD, Goodman KE, Magder LS, Claeys KC, Sutherland ME, Harris AD. Association between delayed broad-spectrum gram-negative antibiotics and clinical outcomes: how much does getting it right with empiric antibiotics matter? Clin Infect Dis. 2025;80:949\u201358.","journal-title":"Clin Infect Dis"},{"key":"5653_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s43856-022-00094-8","volume":"2","author":"CK Corbin","year":"2022","unstructured":"Corbin CK, Sung L, Chattopadhyay A, Noshad M, Chang A, Deresinksi S, et al. Personalized antibiograms for machine learning driven antibiotic selection. Commun Med. 2022;2:38.","journal-title":"Commun Med"},{"key":"5653_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9020050","volume":"9","author":"G Feretzakis","year":"2020","unstructured":"Feretzakis G, Loupelis E, Sakagianni A, Kalles D, Martsoukou M, Lada M, et al. Using machine learning techniques to aid empirical antibiotic therapy decisions in the intensive care unit of a general hospital in Greece. Antibiotics. 2020;9:50.","journal-title":"Antibiotics"},{"key":"5653_CR37","first-page":"75","volume":"272","author":"G Feretzakis","year":"2020","unstructured":"Feretzakis G, Loupelis E, Sakagianni A, Kalles D, Lada M, Christopoulos C, et al. Using machine learning algorithms to predict antimicrobial resistance and assist empirical treatment. Stud Health Technol Inform. 2020;272:75\u20138.","journal-title":"Stud Health Technol Inform"},{"key":"5653_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/e21060603","volume":"21","author":"S Mart\u00ednez-Ag\u00fcero","year":"2019","unstructured":"Mart\u00ednez-Ag\u00fcero S, Mora-Jim\u00e9nez I, L\u00e9rida-Garc\u00eda J, \u00c1lvarez-Rodr\u00edguez J, Soguero-Ruiz C. Machine learning techniques to identify antimicrobial resistance in the intensive care unit. Entropy. 2019;21:603.","journal-title":"Entropy"},{"key":"5653_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00063-21","author":"RJ McGuire","year":"2021","unstructured":"McGuire RJ, Yu SC, Payne PRO, Lai AM, Vazquez-Guillamet MC, Kollef MH, et al. A pragmatic machine learning model to predict carbapenem resistance. Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/aac.00063-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"5653_CR40","doi-asserted-by":"crossref","unstructured":"Pascual-S\u00e1nchez L, Mora-Jim\u00e9nez I, Mart\u00ednez-Ag\u00fcero S, \u00c1lvarez-Rodr\u00edguez J, Soguero-Ruiz C. Predicting Multidrug Resistance Using Temporal Clinical Data and Machine Learning Methods. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) [Internet]. 2021 [cited 2025 Jul 5]. p. 2826\u201333. Available from: https:\/\/ieeexplore.ieee.org\/abstract\/document\/9669829","DOI":"10.1109\/BIBM52615.2021.9669829"},{"key":"5653_CR41","first-page":"430","volume":"295","author":"A Sakagianni","year":"2022","unstructured":"Sakagianni A, Feretzakis G, Kalles D, Loupelis E, Rakopoulou Z, Dalainas I, et al. Discovering association rules in antimicrobial resistance in intensive care unit. Stud Health Technol Inform. 2022;295:430\u20133.","journal-title":"Stud Health Technol Inform"},{"key":"5653_CR42","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/jac\/dkaa222","volume":"75","author":"E Moran","year":"2020","unstructured":"Moran E, Robinson E, Green C, Keeling M, Collyer B. Towards personalized guidelines: using machine-learning algorithms to guide antimicrobial selection. J Antimicrob Chemother. 2020;75:2677\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"5653_CR43","first-page":"43","volume":"281","author":"G Feretzakis","year":"2021","unstructured":"Feretzakis G, Sakagianni A, Loupelis E, Kalles D, Martsoukou M, Skarmoutsou N, et al. Using machine learning to predict antimicrobial resistance of Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa strains. Stud Health Technol Inform. 2021;281:43\u20137.","journal-title":"Stud Health Technol Inform"},{"key":"5653_CR44","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1093\/cid\/ciaa1576","volume":"72","author":"O Lewin-Epstein","year":"2021","unstructured":"Lewin-Epstein O, Baruch S, Hadany L, Stein GY, Obolski U. Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records. Clin Infect Dis. 2021;72:e848-55.","journal-title":"Clin Infect Dis"},{"key":"5653_CR45","doi-asserted-by":"publisher","first-page":"e02236\u201319","DOI":"10.1128\/AAC.02236-19","volume":"64","author":"C Hebert","year":"2020","unstructured":"Hebert C, Gao Y, Rahman P, Dewart C, Lustberg M, Pancholi P, et al. Prediction of antibiotic susceptibility for urinary tract infection in a hospital setting. Antimicrob Agents Chemother. 2020;64:e02236-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"5653_CR46","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/cid\/ciaa383","volume":"72","author":"TM Rawson","year":"2021","unstructured":"Rawson TM, Hernandez B, Moore LSP, Herrero P, Charani E, Ming D, et al. A real-world evaluation of a case-based reasoning algorithm to support antimicrobial prescribing decisions in acute care. Clin Infect Dis. 2021;72:2103\u201311.","journal-title":"Clin Infect Dis"},{"key":"5653_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.abg9868","volume":"375","author":"M Stracy","year":"2022","unstructured":"Stracy M, Snitser O, Yelin I, Amer Y, Parizade M, Katz R, et al. Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections. Science. 2022;375:889\u201394.","journal-title":"Science"},{"key":"5653_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106913","volume":"62","author":"MCV Guillamet","year":"2023","unstructured":"Guillamet MCV, Damulira C, Atkinson A, Fraser VJ, Micek S, Kollef MH. Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant gram-negative bacilli in patients with sepsis and septic shock. Int J Antimicrob Agents. 2023;62:106913.","journal-title":"Int J Antimicrob Agents"},{"key":"5653_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1086\/430912","volume":"41","author":"IA Bliziotis","year":"2005","unstructured":"Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis. 2005;41:149\u201358.","journal-title":"Clin Infect Dis"},{"key":"5653_CR50","doi-asserted-by":"crossref","unstructured":"Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev. 2014;2014:CD003344.","DOI":"10.1002\/14651858.CD003344.pub3"},{"key":"5653_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/j.1875-9114.1995.tb04366.x","volume":"15","author":"DN Fish","year":"1995","unstructured":"Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy. 1995;15:279\u201391.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"5653_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5653_CR53","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1128\/AAC.00867-13","volume":"57","author":"TW Felton","year":"2013","unstructured":"Felton TW, Goodwin J, O\u2019Connor L, Sharp A, Gregson L, Livermore J, et al. Impact of bolus dosing versus continuous infusion of piperacillin and tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57(12):5811\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5653_CR54","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s40262-020-00919-6","volume":"59","author":"S Dhaese","year":"2020","unstructured":"Dhaese S, Heffernan A, Liu D, Abdul-Aziz MH, Stove V, Tam VH, et al. Prolonged versus intermittent infusion of \u03b2-lactam antibiotics: a systematic review and meta-regression of bacterial killing in preclinical infection models. Clin Pharmacokinet. 2020;59:1237\u201350.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"5653_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/cc9091","volume":"14","author":"FS Taccone","year":"2010","unstructured":"Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, et al. Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010;14(4):R126.","journal-title":"Crit Care"},{"issue":"8","key":"5653_CR56","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072\u201383.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5653_CR57","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/jac\/dkad327","volume":"78","author":"AK Smekal","year":"2023","unstructured":"Smekal AK, Furebring M, Lipcsey M, Giske CG. Swedish multicentre study of target attainments with \u03b2-lactams in the ICU: which MIC parameter should be used? J Antimicrob Chemother. 2023;78(12):2895\u2013901.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5653_CR58","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10096-025-05068-x","volume":"44","author":"IA Lejbman","year":"2025","unstructured":"Lejbman IA, Torisson G, Resman F, Sj\u00f6vall F. Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints. Eur J Clin Microbiol Infect Dis. 2025;44(5):1129\u201337.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"5653_CR59","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/phar.2844","volume":"43","author":"LT Hong","year":"2023","unstructured":"Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, et al. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: an executive summary. Pharmacotherapy. 2023;43(8):736\u20139.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"5653_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2023.10598","volume":"330","author":"G Monti","year":"2023","unstructured":"Monti G, Bradic N, Marzaroli M, Konkayev A, Fominskiy E, Kotani Y, et al. Continuous vs intermittent meropenem administration in critically Ill patients with sepsis: The MERCY randomized clinical trial. JAMA. 2023;330(2):141\u201351.","journal-title":"JAMA"},{"issue":"8","key":"5653_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ, et al. Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. 2024;332(8):629\u201337.","journal-title":"JAMA"},{"issue":"8","key":"5653_CR62","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Awele JJ, Devaux A, et al. Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: A systematic review and meta-analysis. JAMA. 2024;332(8):638\u201348.","journal-title":"JAMA"},{"issue":"11","key":"5653_CR63","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1093\/jac\/dky314","volume":"73","author":"G Wong","year":"2018","unstructured":"Wong G, Briscoe S, McWhinney B, Ally M, Ungerer J, Lipman J, et al. Therapeutic drug monitoring of \u03b2-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. J Antimicrob Chemother. 2018;73(11):3087\u201394.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5653_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00134-013-3187-2","volume":"40","author":"JJ De Waele","year":"2014","unstructured":"De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, et al. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med. 2014;40(3):380\u20137.","journal-title":"Intensive Care Med"},{"issue":"3","key":"5653_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","volume":"48","author":"S Hagel","year":"2022","unstructured":"Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, et al. Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med. 2022;48(3):311\u201321.","journal-title":"Intensive Care Med"},{"issue":"12","key":"5653_CR66","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00134-022-06921-9","volume":"48","author":"TMJ Ewoldt","year":"2022","unstructured":"Ewoldt TMJ, Abdulla A, Rietdijk WJR, Muller AE, de Winter BCM, Hunfeld NGM, et al. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med. 2022;48(12):1760\u201371.","journal-title":"Intensive Care Med"},{"issue":"7","key":"5653_CR67","volume":"4","author":"TJ Dilworth","year":"2022","unstructured":"Dilworth TJ, Schulz LT, Micek ST, Kollef MH, Rose WE. \u03b2-Lactam therapeutic drug monitoring in critically ill patients: weighing the challenges and opportunities to assess clinical value. Crit Care Explor. 2022;4(7):e0726.","journal-title":"Crit Care Explor"},{"key":"5653_CR68","doi-asserted-by":"crossref","unstructured":"Tilanus AM, Shields RK, Lodise TP, Drusano GL. Translating PK-PD principles into improved methodology for clinical trials which compare intermittent with prolonged infusion of beta-lactam antibiotics.\u00a0Clin Infect Dis. 2025:ciaf038. Epub ahead of print.","DOI":"10.1093\/cid\/ciaf038"},{"issue":"2","key":"5653_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","volume":"46","author":"A Tabah","year":"2020","unstructured":"Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, et al. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) critically ill patients study group (ESGCIP). Intensive Care Med. 2020;46(2):245\u201365.","journal-title":"Intensive Care Med"},{"issue":"10459","key":"5653_CR70","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"issue":"7","key":"5653_CR71","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00134-020-06111-5","volume":"46","author":"L De Bus","year":"2020","unstructured":"De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, et al. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Med. 2020;46(7):1404\u201317.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5653_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Guti\u00e9rrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fern\u00e1ndez-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32\u201340.","journal-title":"Intensive Care Med"},{"issue":"10","key":"5653_CR73","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K, Lefrant J-Y, Alban\u00e8se J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014;40(10):1399\u2013408.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5653_CR74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00134-013-3148-9","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med. 2014;40(1):41\u20139.","journal-title":"Intensive Care Med"},{"issue":"12","key":"5653_CR75","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1093\/jac\/dkaa375","volume":"75","author":"C Routsi","year":"2020","unstructured":"Routsi C, Gkoufa A, Arvaniti K, Kokkoris S, Tourtoglou A, Theodorou V, et al. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. J Antimicrob Chemother. 2020;75(12):3665\u201374.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"5653_CR76","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/cid\/civ1199","volume":"62","author":"A Tabah","year":"2016","unstructured":"Tabah A, Osbert Cota M, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis. 2016;62(8):1009\u201317.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5653_CR77","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5653_CR78","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8(11):2211\u201325.","journal-title":"Kidney Int Rep"},{"issue":"Suppl 1","key":"5653_CR79","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1093\/jac\/dky530","volume":"74","author":"AA Bhalodi","year":"2019","unstructured":"Bhalodi AA, Van Engelen TSR, Virk HS, Wiersinga WJ. Impact of antimicrobial therapy on the gut microbiome. J Antimicrob Chemother. 2019;74(Suppl 1):i6\u201315.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5653_CR80","doi-asserted-by":"publisher","first-page":"2200910","DOI":"10.1183\/13993003.00910-2022","volume":"61","author":"R Chanderraj","year":"2023","unstructured":"Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, et al. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J. 2023;61(2):2200910.","journal-title":"Eur Respir J"},{"issue":"1","key":"5653_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv186","volume":"3","author":"S Karanika","year":"2016","unstructured":"Karanika S, Paudel S, Zervou FN, Grigoras C, Zacharioudakis IM, Mylonakis E. Prevalence and clinical outcomes of Clostridium difficile infection in the intensive care unit: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;3(1):ofv186.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"5653_CR82","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.idc.2009.04.011","volume":"727","author":"DJ Riddle","year":"2009","unstructured":"Riddle DJ, Dubberke ER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;727(3):727\u201343.","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"5653_CR83","doi-asserted-by":"publisher","first-page":"e00500","DOI":"10.1128\/JCM.00500-18","volume":"56","author":"YP Tabak","year":"2018","unstructured":"Tabak YP, Vankeepuram L, Ye G, Jeffers K, Gupta V, Murray PR. Blood culture turnaround time in U.S. acute care hospitals and implications for laboratory process optimization. J Clin Microbiol. 2018;56(12):e00500-e518.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"5653_CR84","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie AM, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, et al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med. 2022;10(9):877\u201387.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5653_CR85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2023.12.003","volume":"38","author":"CI Pickens","year":"2024","unstructured":"Pickens CI, Wunderink RG. Novel and rapid diagnostics for common infections in the critically ill patient. Infect Dis Clin North Am. 2024;38(1):51\u201363.","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"5653_CR86","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01891-22","volume":"61","author":"DD Rhoads","year":"2023","unstructured":"Rhoads DD, Pournaras S, Leber A, Balada-Llasat J-M, Harrington A, Sambri V, et al. Multicenter evaluation of the BIOFIRE blood culture identification 2 panel for detection of bacteria, yeasts, and antimicrobial resistance genes in positive blood culture samples. J Clin Microbiol. 2023;61(6):e0189122.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5653_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/infdis\/jiad221","volume":"229","author":"AR Falsey","year":"2024","unstructured":"Falsey AR, Branche AR, Croft DP, Formica MA, Peasley MR, Walsh EE. Real-life assessment of BioFire FilmArray pneumonia panel in adults hospitalized with respiratory illness. J Infect Dis. 2024;229(1):214\u201322.","journal-title":"J Infect Dis"},{"issue":"5","key":"5653_CR88","doi-asserted-by":"publisher","first-page":"e02538","DOI":"10.1128\/AAC.02538-17","volume":"62","author":"JM Pogue","year":"2018","unstructured":"Pogue JM, Heil EL, Lephart P, Johnson JK, Mynatt RP, Salimnia H, et al. An antibiotic stewardship program blueprint for optimizing verigene BC-GN within an institution: a tale of two cities. Antimicrob Agents Chemother. 2018;62(5):e02538-e2617.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5653_CR89","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12879-023-08486-4","volume":"23","author":"G Cojuc-Konigsberg","year":"2023","unstructured":"Cojuc-Konigsberg G, Moscona-Nissan A, Guijosa A, Mireles D\u00e1valos CD, Mart\u00ednez MEJ, M\u00fajica S\u00e1nchez MA, et al. Diagnostic accuracy of the biofire\u00ae filmarray\u00ae pneumonia panel in COVID-19 patients with ventilator-associated pneumonia. BMC Infect Dis. 2023;23(1):524.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 7","key":"5653_CR90","doi-asserted-by":"publisher","first-page":"S533","DOI":"10.21037\/jtd.2016.07.28","volume":"8","author":"K Akrami","year":"2016","unstructured":"Akrami K, Sweeney DA, Malhotra A. Antibiotic stewardship in the intensive care unit: tools for de-escalation from the American Thoracic Society Meeting 2016. J Thorac Dis. 2016;8(Suppl 7):S533\u20135.","journal-title":"J Thorac Dis"},{"issue":"11","key":"5653_CR91","doi-asserted-by":"publisher","first-page":"e0007422","DOI":"10.1128\/jcm.00074-22","volume":"61","author":"VM Pierce","year":"2023","unstructured":"Pierce VM, Bhowmick T, Simner PJ. Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023. J Clin Microbiol. 2023;61(11):e0007422.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5653_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12879-023-08493-5","volume":"23","author":"P Guillot","year":"2023","unstructured":"Guillot P, Delamaire F, Gacouin A, Painvin B, Piau C, Reizine F, et al. Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study. BMC Infect Dis. 2023;23(1):611.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5653_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciy024","volume":"67","author":"DM Parente","year":"2018","unstructured":"Parente DM, Cunha CB, Mylonakis E, Timbrook TT. The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications. Clin Infect Dis. 2018;67(1):1\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5653_CR94","volume":"11","author":"S Roper","year":"2023","unstructured":"Roper S, Wingler MJB, Cretella DA. Antibiotic de-escalation in critically ill patients with negative clinical cultures. Pharmacy (Basel). 2023;11(3):104.","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"5653_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.chest.2018.10.014","volume":"155","author":"MC Cowley","year":"2019","unstructured":"Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST. Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia. Chest. 2019;155(1):53\u20139.","journal-title":"Chest"},{"issue":"21","key":"5653_CR96","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372(21):1996\u20132005.","journal-title":"N Engl J Med"},{"issue":"4","key":"5653_CR97","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jama.2021.9899","volume":"326","author":"DM Drekonja","year":"2021","unstructured":"Drekonja DM, Trautner B, Amundson C, Kuskowski M, Johnson JR. Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: a randomized clinical trial. JAMA. 2021;326(4):324\u201331.","journal-title":"JAMA"},{"issue":"11","key":"5653_CR98","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","volume":"392","author":"LR Non","year":"2025","unstructured":"Non LR. Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. N Engl J Med. 2025;392(11):1065\u201378.","journal-title":"N Engl J Med"},{"issue":"9","key":"5653_CR99","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","volume":"176","author":"A Uranga","year":"2016","unstructured":"Uranga A, Espana PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016;176(9):1257\u201365.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"5653_CR100","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","volume":"69","author":"D Yahav","year":"2019","unstructured":"Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5653_CR101","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2213-2600(23)00418-6","volume":"12","author":"Y Mo","year":"2024","unstructured":"Mo Y, Booraphun S, Li AY, Domthong P, Kayastha G, Lau YH, et al. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial. Lancet Respir Med. 2024;12(5):399\u2013408.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"5653_CR102","doi-asserted-by":"publisher","first-page":"e00635","DOI":"10.1128\/AAC.00635-18","volume":"62","author":"GS Tansarli","year":"2018","unstructured":"Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother. 2018;62(9):e00635-e718.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5653_CR103","doi-asserted-by":"publisher","first-page":"e061023","DOI":"10.1136\/bmjopen-2022-061023","volume":"13","author":"Y Furukawa","year":"2023","unstructured":"Furukawa Y, Luo Y, Funada S, Onishi A, Ostinelli E, Hamza T, et al. Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis. BMJ Open. 2023;13(3):e061023.","journal-title":"BMJ Open"},{"issue":"7","key":"5653_CR104","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45-67.","journal-title":"Am J Respir Crit Care Med"},{"key":"5653_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154346","volume":"78","author":"HA Cheema","year":"2023","unstructured":"Cheema HA, Ellahi A, Hussain HU, Kashif H, Adil M, Kumar D, et al. Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2023;78:154346.","journal-title":"J Crit Care"},{"key":"5653_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101880","volume":"58","author":"MA Daghmouri","year":"2023","unstructured":"Daghmouri MA, Dudoignon E, Chaouch MA, Baekgaard J, Bougle A, Leone M, et al. Comparison of a short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. eClinicalMedicine. 2023;58:101880.","journal-title":"eClinicalMedicine"},{"issue":"5","key":"5653_CR107","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-111.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5653_CR108","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.317","volume":"2","author":"B Elajouz","year":"2022","unstructured":"Elajouz B, Dumkow LE, Worden LJ, VanLangen KM, Jameson AP. Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e171.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"9","key":"5653_CR109","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(20)30121-3","volume":"20","author":"DK Kim","year":"2020","unstructured":"Kim DK, Kim JH, Lee JY, Ku NS, Lee HS, Park JY, et al. Reappraisal of the treatment duration of antibiotic regimens for acute uncomplicated cystitis in adult women: a systematic review and network meta-analysis of 61 randomised clinical trials. Lancet Infect Dis. 2020;20(9):1080\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"5653_CR110","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/jac\/dkt177","volume":"68","author":"N Eliakim-Raz","year":"2013","unstructured":"Eliakim-Raz N, Yahav D, Paul M, Leibovici L. Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection\u2013 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2013;68(10):2183\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"5653_CR111","unstructured":"Zahavi I, Kunwar D, Olchowski J, Dallasheh H, Paul M. Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect. 2025;12:S1198-743X(25)00171-5."},{"issue":"4","key":"5653_CR112","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/TA.0000000000003998","volume":"95","author":"JH Ra","year":"2023","unstructured":"Ra JH, Rattan R, Patel NJ, Bhattacharya B, Butts CA, Gupta S, et al. Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: a systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2023;95(4):603\u201312.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"5653_CR113","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1089\/sur.2017.011","volume":"18","author":"SE Smith","year":"2017","unstructured":"Smith SE, Rumbaugh KA, May AK. Evaluation of a short course of antimicrobial therapy for complicated intra-abdominal infections in critically ill surgical patients. Surg Infect (Larchmt). 2017;18(6):742\u201350.","journal-title":"Surg Infect (Larchmt)"},{"issue":"5","key":"5653_CR114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/sur.2023.037","volume":"24","author":"NB Lyons","year":"2023","unstructured":"Lyons NB, Cohen BL, O\u2019Neil CF, Ramsey WA, Proctor KG, Namias N, et al. Short versus long antibiotic duration for necrotizing soft tissue infection: A systematic review and meta-analysis. Surg Infect (Larchmt). 2023;24(5):425\u201332.","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"5653_CR115","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-52.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5653_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13017-022-00406-2","volume":"17","author":"M Sartelli","year":"2022","unstructured":"Sartelli M, Coccolini F, Kluger Y, Agastra E, Abu-Zidan FM, Abbas AES, et al. WSES\/GAIS\/WSIS\/SIS-E\/AAST global clinical pathways for patients with skin and soft tissue infections. World J Emerg Surg. 2022;17(1):3.","journal-title":"World J Emerg Surg"},{"key":"5653_CR117","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.1421","volume":"8","author":"TC Lee","year":"2025","unstructured":"Lee TC, Prosty CJ, Fralick M, Huttner A, McDonald EG, Molina J, et al. Seven vs fourteen days of antibiotics for gram-negative bloodstream infection: a systematic review and noninferiority meta-analysis. JAMA Netw Open. 2025;8:e251421.","journal-title":"JAMA Netw Open"},{"key":"5653_CR118","doi-asserted-by":"crossref","unstructured":"Prager M, Bergmann F, Pracher L, Copic D, Zessner-Spitzenberg J, Gelbenegger G, et al. Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trials. Infection. 2025. Online ahead of print.","DOI":"10.1007\/s15010-025-02562-4"},{"issue":"1","key":"5653_CR119","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13613-017-0296-z","volume":"7","author":"E Yusuf","year":"2017","unstructured":"Yusuf E, Van Herendael B, Verbrugghe W, Ieven M, Goovaerts E, Bergs K, et al. Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration. Ann Intensive Care. 2017;7(1):72.","journal-title":"Ann Intensive Care"},{"key":"5653_CR120","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"5653_CR121","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2024.26458","volume":"333","author":"P Dark","year":"2025","unstructured":"Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, et al. Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. JAMA. 2025;333(8):682\u201393.","journal-title":"JAMA"},{"issue":"9713","key":"5653_CR122","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt C-E, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374.","journal-title":"Lancet"},{"issue":"23","key":"5653_CR123","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1001\/jama.2022.18623","volume":"328","author":"M Bonten","year":"2022","unstructured":"Bonten M. Selective decontamination of the digestive tract: an answer at last? JAMA. 2022;328(23):2310\u20131.","journal-title":"JAMA"},{"issue":"19","key":"5653_CR124","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1001\/jama.2022.17927","volume":"328","author":"JA Myburgh","year":"2022","unstructured":"SuDDICU Investigators, Myburgh JA, Seppelt IM, Goodman F, Billot L, Correa M, et al. Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation: a randomized clinical trial. JAMA. 2022;328(19):1911\u201321.","journal-title":"JAMA"},{"issue":"8","key":"5653_CR125","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00134-023-07100-0","volume":"49","author":"JJ De Waele","year":"2023","unstructured":"De Waele JJ, Leroux-Roels I, Depuydt P. Selective digestive decontamination - Pro. Intensive Care Med. 2023;49(8):979\u201381.","journal-title":"Intensive Care Med"},{"issue":"8","key":"5653_CR126","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00134-023-07115-7","volume":"49","author":"WJ Wiersinga","year":"2023","unstructured":"Wiersinga WJ. Selective digestive decontamination- not sure. Intensive Care Med. 2023;49(8):984\u20136.","journal-title":"Intensive Care Med"},{"issue":"19","key":"5653_CR127","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1001\/jama.2022.19709","volume":"328","author":"NE Hammond","year":"2022","unstructured":"Hammond NE, Myburgh J, Seppelt I, Garside T, Vlok R, Mahendran S, et al. Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA. 2022;328(19):1922\u201334.","journal-title":"JAMA"},{"issue":"20","key":"5653_CR128","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1001\/jama.2018.13765","volume":"320","author":"BH Wittekamp","year":"2018","unstructured":"Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, et al. Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients: a randomized clinical trial. JAMA. 2018;320(20):2087\u201398.","journal-title":"JAMA"},{"issue":"6","key":"5653_CR129","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","volume":"46","author":"M Karvouniaris","year":"2015","unstructured":"Karvouniaris M, Makris D, Zygoulis P, Triantaris A, Xitsas S, Mantzarlis K, et al. Nebulised colistin for ventilator-associated pneumonia prevention. Eur Respir J. 2015;46(6):1732\u20139.","journal-title":"Eur Respir J"},{"issue":"22","key":"5653_CR130","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","volume":"389","author":"S Ehrmann","year":"2023","unstructured":"Ehrmann S, Barbier F, Demiselle J, Quenot JP, Herrecht JE, Roux D, et al. Inhaled amikacin to prevent ventilator-associated pneumonia. N Engl J Med. 2023;389(22):2052\u2013627.","journal-title":"N Engl J Med"},{"issue":"10","key":"5653_CR131","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/CCM.0000000000006323","volume":"52","author":"J Li","year":"2024","unstructured":"Li J, Lyu S, Luo J, Liu P, Albuainain FA, Alamoudi OA, et al. Prophylactic antibiotics delivered via the respiratory tract to reduce ventilator-associated pneumonia: a systematic review, network meta-analysis, and trial sequential analysis of randomized controlled trials. Crit Care Med. 2024;52(10):1612\u201323.","journal-title":"Crit Care Med"},{"issue":"5","key":"5653_CR132","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S2213-2600(23)00471-X","volume":"12","author":"C Dahyot-Fizelier","year":"2024","unstructured":"Dahyot-Fizelier C, Lasocki S, Kerforne T, Perrigault PF, GeeraertsAsehnoune, T, et al. Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: A multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. Lancet Respir Med. 2024;12(5):375\u201385.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"5653_CR133","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/CCM.0000000000004344","volume":"48","author":"KK Trivedi","year":"2020","unstructured":"Trivedi KK, Bartash R, Letourneau AR, Abbo L, Fleisher J, Gagliardo C, et al. Opportunities to improve antibiotic appropriateness in U.S. ICUs: a multicenter evaluation. Crit Care Med. 2020;48(7):968\u201376.","journal-title":"Crit Care Med"},{"issue":"4","key":"5653_CR134","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1086\/664771","volume":"33","author":"SE Cosgrove","year":"2012","unstructured":"Cosgrove SE, Seo SK, Bolon MK, Sepkowitz KA, Climo MW, Diekema DJ, et al. CDC prevention epicenter program: Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: A multicenter intervention. Infect Control Hosp Epidemiol. 2012;33(4):374\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"5653_CR135","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1164\/rccm.200809-1394CP","volume":"179","author":"KL Lawrence","year":"2009","unstructured":"Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med. 2009;179(6):434\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5653_CR136","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1513\/AnnalsATS.202003-188ST","volume":"17","author":"RG Wunderink","year":"2020","unstructured":"Wunderink RG, Srinivasan A, Barie PS, Chastre J, Dela Cruz CS, Douglas IS, et al. Antibiotic stewardship in the intensive care unit. An official American Thoracic Society workshop report in collaboration with the AACN, CHEST, CDC, and SCCM. Ann Am Thorac Soc. 2020;17(5):531\u201340.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"5653_CR137","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1017\/ice.2019.381","volume":"41","author":"BF Teshome","year":"2020","unstructured":"Teshome BF, Vouri SM, Hampton NB, Kollef MH, Micek ST. Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill. Infect Control Hosp Epidemiol. 2020;41(4):484\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"5653_CR138","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","volume":"125","author":"ST Micek","year":"2004","unstructured":"Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125(5):1791\u20139.","journal-title":"Chest"},{"issue":"9","key":"5653_CR139","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ajic.2015.04.200","volume":"43","author":"F Arena","year":"2015","unstructured":"Arena F, Scolletta S, Marchetti L, Galano A, Maglioni E, Giani T, et al. Impact of a clinical microbiology-intensive care consulting program in a cardiothoracic intensive care unit. Am J Infect Control. 2015;43(9):1018\u201321.","journal-title":"Am J Infect Control"},{"issue":"3","key":"5653_CR140","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jointm.2022.10.001","volume":"3","author":"Z Ture","year":"2023","unstructured":"Ture Z, G\u00fcner R, Alp E. Antimicrobial stewardship in the intensive care unit. J Intensive Med. 2023;3(3):244\u201353.","journal-title":"J Intensive Med"},{"issue":"4","key":"5653_CR141","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/jpids\/piy043","volume":"8","author":"MC Astorga","year":"2019","unstructured":"Astorga MC, Piscitello KJ, Menda N, Ebert AM, Ebert SC, Porte MA, et al. Antibiotic stewardship in the neonatal intensive care unit: effects of an automatic 48-hour antibiotic stop order on antibiotic use. J Pediatr Infect Dis Soc. 2019;8(4):310\u20136.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"6","key":"5653_CR142","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/PCC.0000000000001925","volume":"20","author":"SM Adams","year":"2019","unstructured":"Adams SM, Ngo L, Morphew T, Babbitt CJ. Does an antimicrobial time-out impact the duration of therapy of antimicrobials in the PICU. Pediatr Crit Care Med. 2019;20(6):560\u20137.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"5653_CR143","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciw649","volume":"64","author":"TT Timbrook","year":"2017","unstructured":"Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis. 2017;64(1):15\u201323.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5653_CR144","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/aas.14516","volume":"68","author":"S Wichmann","year":"2024","unstructured":"Wichmann S, Christensen D\u00d8, Jensen CAJ, Bangsborg J, Kolpen M, Bestle MH. Antibiotic stewardship with multiplex PCR for pneumonia in intensive care patients: a retrospective study. Acta Anaesthesiol Scand. 2024;68(10):1456\u201362.","journal-title":"Acta Anaesthesiol Scand"},{"key":"5653_CR145","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13054-023-04677-2","volume":"27","author":"M Papp","year":"2023","unstructured":"Papp M, Kiss N, Baka M, Tr\u00e1sy D, Zubek L, Feh\u00e9rv\u00e1ri P, et al. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival\u2014a systematic review and meta-analysis. Crit Care. 2023;27:394.","journal-title":"Crit Care"},{"issue":"7","key":"5653_CR146","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5653_CR147","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1164\/rccm.202004-1201OC","volume":"203","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, et al. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med. 2021;203(2):202\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5653_CR148","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cid\/ciae591","volume":"80","author":"KQ Kam","year":"2025","unstructured":"Kam KQ, Chen T, Kadri SS, Lawandi L, Yek C, Walker M, et al. Epidemiology and outcomes of antibiotic de-escalation in patients with suspected sepsis in us hospitals. Clin Infect Dis. 2025;80(1):108\u201317.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5653_CR149","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/cid\/ciae253","volume":"79","author":"BF Teshome","year":"2024","unstructured":"Teshome BF, Park T, Arackal J, Hampton N, Kollef MH, Micek ST. Preventing new gram-negative resistance through beta-lactam de-escalation in hospitalized patients with sepsis: a retrospective cohort study. Clin Infect Dis. 2024;79(4):826\u201333.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5653_CR150","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/antibiotics13040375","volume":"13","author":"ES Tanzarella","year":"2024","unstructured":"Tanzarella ES, Cutuli SL, Lombardi G, Cammarota F, Caroli A, Franchini E, et al. Antimicrobial de-escalation in critically ill patients. Antibiotics. 2024;13(4):375.","journal-title":"Antibiotics"},{"issue":"8","key":"5653_CR151","doi-asserted-by":"publisher","first-page":"e0183062","DOI":"10.1371\/journal.pone.0183062","volume":"12","author":"CE Curtis","year":"2017","unstructured":"Curtis CE, Al Bahar F, Marriott JF. The effectiveness of computerised decision support on antibiotic use in hospitals: a systematic review. PLoS ONE. 2017;12(8):e0183062.","journal-title":"PLoS ONE"},{"issue":"5","key":"5653_CR152","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.10180","volume":"5","author":"TM Ng","year":"2022","unstructured":"Ng TM, Heng ST, Chua BH, Ang LW, Tan SH, Tay HL, et al. Sustaining antimicrobial stewardship in a high-antibiotic resistance setting. JAMA Netw Open. 2022;5(5):e2210180.","journal-title":"JAMA Netw Open"},{"key":"5653_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s44259-024-00068-x","volume":"3","author":"A Cesaro","year":"2025","unstructured":"Cesaro A, Hoffman SC, Das P, de la Fuente-Nunez C. Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance. NPJ Antimicrob Resist. 2025;3:2.","journal-title":"NPJ Antimicrob Resist"},{"issue":"11","key":"5653_CR154","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/cid\/ciab747","volume":"74","author":"JL Seidelman","year":"2022","unstructured":"Seidelman JL, Turner NA, Wrenn RH, Sarubbi C, Anderson DJ, Sexton DJ, et al. Impact of antibiotic stewardship rounds in the intensive care setting: a prospective cluster-randomized crossover study. Clin Infect Dis. 2022;74(11):1986\u201392.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5653_CR155","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13613-023-01134-9","volume":"13","author":"D Mokrani","year":"2023","unstructured":"Mokrani D, Chommeloux J, Pineton de Chambrun M, H\u00e9kimian G, Luyt CE, et al. Antibiotic stewardship in the ICU: time to shift into overdrive. Ann Intensive Care. 2023;13(1):39.","journal-title":"Ann Intensive Care"},{"key":"5653_CR156","unstructured":"New tool for assessing antibiotic stewardship in global inpatient healthcare facilities. https:\/\/www.cdc.gov\/international-infection-control\/php\/stories\/ams-tool.html (accessed 18 July 2025)."},{"issue":"2","key":"5653_CR157","doi-asserted-by":"publisher","first-page":"e211072","DOI":"10.1001\/jamanetworkopen.2021.1072","volume":"4","author":"JC McGregor","year":"2021","unstructured":"McGregor JC, Fitzpatrick MA, Suda KJ. Expanding antimicrobial stewardship through quality improvement. JAMA Netw Open. 2021;4(2):e211072.","journal-title":"JAMA Netw Open"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05653-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:02:17Z","timestamp":1769119337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05653-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":157,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5653"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05653-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}